Action:
Drug Reference
Action 539
General Information
| Action Summary |
The current edition of "Drug Facts and Comparisons" has rearranged the listing of opthalmic drugs. The amendment corrects the reference in regulation. |
| Chapters Affected |
Only affects this chapter.
|
| Executive Branch Review |
This Action is exempt from Article 2 of the Administrative Process Act.
The normal executive branch review process is not required. As such, it can be submitted directly for publication and
is effective upon publication.
Exempt Citation:
9-6.14:4(C)(3)
|
| RIS Project |
No project yet assigned to this action |
| New Periodic Review |
This action will not be used to conduct a new periodic review.
|
Stages
Stages associated with this regulatory action.
| Stage ID |
Stage Type |
Status |
|
794
|
Final
|
Stage complete. This regulation became effective on 07/19/2000. |
Contact Information
|
Name / Title:
|
Leslie L. Knachel
/
Executive Director
|
|
Address:
|
9960 Mayland Drive
Suite 300
Henrico, VA 23233
|
|
Email Address:
|
leslie.knachel@dhp.virginia.gov
|
|
Phone:
|
(804)597-4130
FAX: (804)793-9145
TDD: ()-
|
This person is the primary contact for this board.
